A chemical family-based strategy for uncovering hidden bioactive molecules and multicomponent interactions in herbal medicines

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Song, Hui Peng ^a   Wu, Si Qi ^a   Hao, Haiping ^a   Chen, Jun ^a   Lu, Jun ^a   Xu, Xiaojun ^a   Li, Ping ^a   Yang, Hua ^a  

^a China Pharmaceutical University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; HERBACEOUS AGENT; MOLECULAR LIBRARY;

CHEMISTRY; DRUG DEVELOPMENT; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MEDICINAL PLANT; MOLECULAR LIBRARY; PANAX NOTOGINSENG; SALVIA MILTIORRHIZA;

ANTITHROMBINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DISCOVERY; DRUGS, CHINESE HERBAL; HERBAL MEDICINE; PANAX NOTOGINSENG; PLANTS, MEDICINAL; SALVIA MILTIORRHIZA; SMALL MOLECULE LIBRARIES;

EID: 84962415073     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23840     Document Type: Article

References (53)

1. Welsch, M. E., Snyder, S. A. & Stockwell, B. R. Privileged scaffolds for library design and drug discovery. Curr. Opin. Chem. Biol. 14, 347-361 (2010).
2. Ma, D. L. et al. Virtual screening and optimization of Type II inhibitors of JAK2 from a natural product library. Chem. Commun. 50, 13885-13888 (2014).
3. Harvey, A. L. Natural products in drug discovery. Drug Discov. Today 13, 894-901 (2008).
4. Harvey, A. L. Natural products as a screening resource. Curr. Opin. Chem. Biol. 11, 480-484 (2007).
5. Koehn, F. E. & Carter, G. T. The evolving role of natural products in drug discovery. Nat. rev. drug discov. 4, 206-220 (2005).
6. Faulkner, D. J. Marine natural products. Nat. Prod. Rep. 17, 7-55 (2000).
7. Lien, C. W., Huang, C. C. & Chang, H. T. Peroxidase-mimic bismuth-gold nanoparticles for determining the activity of thrombin and drug screening. Chem. Commun. 48, 7952-7954 (2012).
8. Inglese, J. et al. High-throughput screening assays for the identification of chemical probes. Nat. Chem. Biol. 3, 466-479 (2007).
9. Cullen, W., Turega, S., Hunter, C. A. & Ward, M. D. Virtual screening for high affinity guests for synthetic supramolecular receptors. Chem. Sci. 6, 2790-2794 (2015).
10. Ng, E. S. M. et al. High-throughput screening for enzyme inhibitors using frontal affinity chromatography with liquid chromatography and mass spectrometry. Anal. Chem. 77, 6125-6133 (2005).
11. Schramek, N., Wollein, U. & Eisenreich, W. Identification of new synthetic PDE-5 inhibitors analogues found as minor components in a dietary supplement. J. Pharm. Biomed. Anal. 96, 45-53 (2014).
12. Odendaal, A. Y., Trader, D. J. & Carlson, E. E. Chemoselective enrichment for natural products discovery. Chem. Sci. 2, 760-764 (2011).
13. Hasani-Ranjbar, S., Nayebi, N., Larijani, B. & Abdollahi, M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J. Gastroenterol. 15, 3073-3085 (2009).
14. Zhou, H. H., Sun, L. T., Yang, X. L. & Schimmel, P. ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase. Nature 494, 121-124 (2013).
15. Kawamura, S. et al. Rational hopping of a peptidic scaffold into non-peptidic scaffolds: structurally novel potent proteasome inhibitors derived from a natural product, belactosin A. Chem. Commun. 50, 2445-2447 (2014).
16. Deng, X., Shi, S. Y., Li, S. M. & Yang, T. L. Magnetic ligand fishing combination with high-performance liquid chromatographydiode array detector-mass spectrometry to screen and characterize cyclooxygenase-2 inhibitors from green tea. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 973, 55-60 (2014).
17. Li, J. W. H. & Vederas, J. C. Drug discovery and natural products: end of an era or an endless frontier? Science 325, 161-165 (2009).
18. Song, H. P. et al. A strategy for screening of high-quality enzyme inhibitors from herbal medicines based on ultrafiltration LC-MS and in silico molecular docking. Chem. Commun. 51, 1494-1497 (2015).
19. Lee, H. M. et al. Identification of natural product Fonsecin B as a stabilizing ligand of c-myc G-quadruplex DNA by high-throughput virtual screening. Chem. Commun. 46, 4680-4682 (2010).
20. Song, H. P. et al. Screening for selective inhibitors of xanthine oxidase from Flos Chrysanthemum using ultrafiltration LC-MS combined with enzyme channel blocking. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 961, 56-61 (2014).
21. Liu, P. et al. Bioactive equivalence of combinatorial components identified in screening of an herbal medicine. Pharm. Res. 31, 1788-1800 (2014).
22. Li, P. et al. Analysis of Chinese herbal medicines with holistic approaches and integrated evaluation models. Trend. Anal. Chem. 27, 66-77 (2008).
23. Patwardhan, B. & Mashelkar, R. A. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward? Drug Discov. Today 14, 804-811 (2009).
24. Qiu, J. Traditional medicine: a culture in the balance. Nature 448, 126-128 (2007).
25. Wang, S. P. et al. Compatibility art of traditional Chinese medicine: from the perspective of herb pairs. J. Ethnopharmacol. 143, 412-423 (2012).
26. Chen, G. et al. The anti-diabetic effects and pharmacokinetic profiles of berberine in mice treated with Jiao-Tai-Wan and its compatibility. Phytomedicine 20, 780-786 (2013).
27. Heras, M. et al. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation 79, 657-665 (1989).
28. Li, X. X. et al. A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment. PLoS ONE 7, e43918 (2012).
29. Lucio-Gutiérrez, J. R., Coello, J. & Maspoch, S. Enhanced chromatographic fingerprinting of herb materials by multi-wavelength selection and chemometrics. Anal. Chim. Acta 710, 40-49 (2012).
30. Zang, Q. C. et al. Searching for the main anti-bacterial components in artificial Calculus bovis using UPLC and microcalorimetry coupled with multi-linear regression analysis. J. Sep. Sci. 34, 3330-3338 (2011).
31. Greenbaum, D. C. et al. Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. Chem. Biol. 9, 1085-1094 (2002).
32. Xu, J. Z., Zeng, S. S., Chen, X. Y. & Qu, H. B. Isolation and identification of degradation products of salvianolic acid A by NMR and LC-MS. Fitoterapia 82, 260-266 (2011).
33. Chou, T. C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 70, 440-446 (2010).
34. Chou, T. C. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev. 58, 621-681 (2006).
35. Zhao, L., Wientjes, M. G. & Au, J. L-S. Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses. Clin. Cancer Res. 10, 7994-8004 (2004).
36. Davie, E. W. & Kulman, J. D. An overview of the structure and function of thrombin. Semin. Thromb. Hemost. 32, 3-15 (2006).
37. Hadjipavlou-Litina, D. QSAR and Molecular Modeling Studies of Factor Xa and Thrombin Inhibitors. Top Heterocycl. Chem. 4, 1-53 (2006).
38. Tabernoa, L. et al. Structure of a Retro-binding Peptide Inhibitor Complexed with Human α -Thrombin. J. Mol. Biol. 246, 14-20 (1995).
39. Linusson, A. et al. Statistical molecular design, parallel synthesis, and biological evaluation of a library of thrombin inhibitors. J. Med. Chem. 44, 3424-3439 (2001).
40. Zhang, Y. et al. Tanshinones: sources, pharmacokinetics and anti-cancer activities. Int. J. Mol. Sci. 13, 13621-13666 (2012).
41. Wong, K. K. K. et al. Interaction study of two diterpenes, cryptotanshinone and dihydrotanshinone, to human acetylcholinesterase and butyrylcholinesterase by molecular docking and kinetic analysis. Chem. Biol. Interact. 187, 335-339 (2010).
42. Qiu, F. et al. Quantitative purity-activity relationships of natural products: the case of anti-tuberculosis active triterpenes from Oplopanax horridus. J. Nat. Prod. 76, 413-419 (2013).
43. Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311-335 (2012).
44. Zhao, H. D. et al. Analysis and improved characterization of minor antioxidants from leaves of Malus doumeri using a combination of major constituents' knockout with high-performance liquid chromatography-diode array detector-quadrupole time-of-flight tandem mass spectrometry. J. Chromatogr. A 1398, 57-65 (2015).
45. Hou, J. J. et al. Ruggedness and robustness of conversion factors in method of simultaneous determination of multi-components with single reference standard. J. Chromatogr. A 1218, 5618-5627 (2011).
46. El-Seedi, H. R. et al. The traditional medical uses and cytotoxic activities of sixty-one Egyptian plants: discovery of an active cardiac glycoside fromUrginea maritima. J. Ethnopharmacol. 145, 746-757 (2013).
47. Demma, J. et al. An in vitro study on the DNA damaging effects of phytochemicals partially isolated from an extract of Glinus lotoides. Phytother. Res. 27, 507-514 (2013).
48. Sadqi, M., Lapidus, L. J. & Munoz, V. How fast is protein hydrophobic collapse? Proc. Natl. Acad. Sci. USA 100, 12117-12122 (2003).
49. Agashe, V. R., Shastry, M. C. R. & Udgaonkar, J. B. Initial hydrophobic collapse in the folding of barstar. Nature 377, 754-757 (1995).
50. Zhou, R. H., Huang, X. H., Margulis, C. J. & Berne, B. J. Hydrophobic collapse in multidomain protein folding. Science 305, 1605-1609 (2004).
51. Bijak, M., Saluk, J., Ponczek, M. B. & Nowak, P. Antithrombin effect of polyphenol-rich extracts from black chokeberry and grape seeds. Phytother. Res. 27, 71-76 (2013).
52. Chou, T. C. & Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22, 27-55 (1984).
53. Rodea-Palomares, I. et al. Application of the combination index (CI)-isobologram equation to study the toxicological interactions of lipid regulators in two aquatic bioluminescent organisms. Water Res. 44, 427-438 (2010).